Nasdaq
$0.8987▼ 3.37%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $7.8MShares out 8.7M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
10- 10.5Pre-market26.10.05 22:208-KKey event#●●●#●●●#●●●
NEUROONE MEDICAL TECHNOLOGIES CorpBullish
NeuroOne Medical Technologies announced that its fiscal year 2026 revenue reached approximately $10.5 million, hitting the top end of its guidance range. The company also secured a record $4.5 million purchase order in September 2026, with shipments scheduled to begin in the first quarter of fiscal 2027.…more
$0.8987-3.37%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.8Pre-market26.09.08 21:314Ownership
NEUROONE MEDICAL TECHNOLOGIES Corp
Insider David J. Wambeke of NeuroOne Medical Technologies Corp reported a change in beneficial ownership of securities effective August 27, 2026. This filing provides the details of the insider transaction in accordance with Form 4.…more
$0.8987-3.37%vs prev closeView filingShare - 8.28After-hours26.08.29 06:294Ownership
NEUROONE MEDICAL TECHNOLOGIES Corp
NeuroOne Medical Technologies Corp insider Emily J. Johns filed a Form 4 on August 28, 2026, reporting changes in beneficial ownership of securities. This filing serves as an official record of equity changes by company management, reflecting the current status of insider holdings.…more
$0.8987-3.37%vs prev closeView filingShare
9 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 3d agoPre-market26.10.22 21:31#●●●#●●●
NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Platform…more
NeuroOne has secured its first purchase order from a Tier 1 global pharmaceutical company to use its StereoCED drug delivery platform for preclinical research. This milestone marks a strategic step toward establishing the technology as a standard in the drug development process.…more
$0.8987-3.37%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.8After-hours26.10.09 05:01
●●●●●●●● ●●●●● ●●●●●●
NeuroOne has joined a Dartmouth-led research team to advance neurotransmitter sensing technology with a $1 million NIH grant. The company will receive approximately $200,000 to integrate its electrode technology for real-time brain activity monitoring.…more
$0.8987-3.37%vs prev close - 10.5Pre-market26.10.05 22:17
●●●●●●●● ●●●●● ●●●●●●
NeuroOne announced that its fiscal Q4 2026 product revenue grew 38.4% year-over-year, meeting the top end of its guidance. The company also secured a record $4.5 million purchase order, strengthening its revenue outlook for the upcoming fiscal year.…more
$0.8987-3.37%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report